Northwest Biotherapeutics, Inc. (NWBO) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.24, down from yesterday’s close by -0.74%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Northwest Biotherapeutics, Inc. (NWBO) currently trades with a market capitalization of $51.03 Million. That value represents a market adjusting for revenues that have been falling by -6.92 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$35.98 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0 on a per share basis this quarter. Perhaps, that suggests something about why 1.68% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Northwest Biotherapeutics, Inc. recorded a 52-week high of $0.32. It is now trading 0.08% off that level. The stock is trading $0.2181 its 50-day moving average by -0.0219%. The stock carved out a 52-week low down at $0.16.
In recent action, Northwest Biotherapeutics, Inc. (NWBO) has made a move of -12.89% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 9.56% with $147.90 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of NWBO.